University of Minnesota. Driven to Discover.
The shorter, simpler regimen with the new drug is poised to improve treatment against a difficult disease and to lower costs.
Genomic analysis suggests C difficile strains that have spread in hospitals belong to an emerging species.
Skepticism remains in some high-income nations, with France having the lowest trust in vaccines.
The sample was from 2014, so the discovery has implications for the US spread of colistin resistance.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.